Caution for interstitial lung disease as a cause of CA 15-3 rise in advanced breast cancer patients treated with everolimusWILLEMSEN, Annelieke E. C. A. B; GRUTTERS, Jan C; GERRITSEN, Winald R et al.International journal of cancer (Print). 2014, Vol 135, Num 4, issn 0020-7136, p. 1007Article

Case 1. Mediastinal sarcoidosis in a melanoma patient treated with interferonHENDRICKX, Baudewijn W; VAN HERPEN, Carla M. L; BONENKAMP, Johannes J et al.Journal of clinical oncology. 2005, Vol 23, Num 34, pp 8906-8907, issn 0732-183X, 2 p.Article

LONG-TERM OUTCOME AND MORBIDITY AFTER TREATMENT WITH ACCELERATED RADIOTHERAPY AND WEEKLY CISPLATIN FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER: RESULTS OF A MULTIDISCIPLINARY LATE MORBIDITY CLINICRÜTTEN, Heidi; POP, Lucas A. M; JANSSENS, Geert O. R. J et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 4, pp 923-929, issn 0360-3016, 7 p.Article

Phase III Study of Gefitinib 250 Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and NeckSTEWART, J. Simon W; COHEN, Ezra E. W; VARELLA-GARCIA, Marileila et al.Journal of clinical oncology. 2009, Vol 27, Num 11, pp 1864-1871, issn 0732-183X, 8 p.Article

Quantification of Patient-Specific Assay Interference in Different Formats of Enzyme-Linked Immunoassays for Therapeutic Monoclonal AntibodiesGREBENCHTCHIKOV, Nicolai; GEURTS-MOESPOT, Anneke J; HEIJMEN, Linda et al.Therapeutic drug monitoring. 2014, Vol 36, Num 6, pp 765-770, issn 0163-4356, 6 p.Article

Role of Endogenous Vascular Endothelial Growth Factor in Endothelium-Dependent Vasodilation in HumansTHIJS, Anna M. J; VAN HERPEN, Carla M. L; SWEEP, Fred C. G. J et al.Hypertension (Dallas, Tex. 1979). 2013, Vol 61, Num 5, pp 1060-1065, issn 0194-911X, 6 p.Article

Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumoursVAN CRUIJSEN, Hester; VOEST, Emile E; VAN HERPEN, Carla M. L et al.European journal of cancer (1990). 2010, Vol 46, Num 5, pp 901-911, issn 0959-8049, 11 p.Article

Diagnostic challenges of respiratory adverse events during everolimus treatmentWILLEMSEN, Annclieke E. C. A. B; DE VOS, Filip Y; JANSEN, Anne et al.Targeted oncology. 2014, Vol 9, Num 3, pp 287-291, issn 1776-2596, 5 p.Article

Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1VAN HERPEN, Carla M. L; BUSSINK, Johan; VAN DER KOGEL, Albert J et al.Anticancer research. 2005, Vol 25, Num 2A, pp 1015-1021, issn 0250-7005, 7 p.Article

Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumorVAN HERPEN, Carla M. L; VAN DER LAAK, Jeroen A. W. M; DE VRIES, I. Jolanda M et al.Clinical cancer research. 2005, Vol 11, Num 5, pp 1899-1909, issn 1078-0432, 11 p.Article

Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx^®)BOERS-SONDEREN, Marye J; VAN HERPEN, Carla M. L; VAN DER GRAAF, Winette T. A et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 3, pp 457-463, issn 0344-5704, 7 p.Article

Phase I Clinical and Magnetic Resonance Imaging Study of the Vascular Agent NGR-hTNF in Patients with Advanced Cancers (European Organization for Research and Treatment of Cancer Study 16041)VAN LAARHOVEN, Hanneke W. M; FIEDLER, Walter; LAMBIASE, Antonio et al.Clinical cancer research (Print). 2010, Vol 16, Num 4, pp 1315-1323, issn 1078-0432, 9 p.Article

Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CTBOERS-SONDEREN, Marye J; DE GEUS-OEI, Lioe-Fee; DESAR, Ingrid M. E et al.Targeted oncology. 2014, Vol 9, Num 4, pp 339-347, issn 1776-2596, 9 p.Article

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patientsDESAR, Ingrid M. E; JACOBS, J. F. M; HULSBERGEN-VANDEKAA, Christina A et al.International journal of cancer (Print). 2011, Vol 129, Num 2, pp 507-512, issn 0020-7136, 6 p.Article

The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced CancerBANERJI, Udai; CAMIDGE, D. Ross; BROWN, Kathryn H et al.Clinical cancer research (Print). 2010, Vol 16, Num 5, pp 1613-1623, issn 1078-0432, 11 p.Article

Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activationVAN HERPEN, Carla M. L; VAN DER VOORT, Robbert; VAN KRIEKEN, Johan H et al.International journal of cancer. 2008, Vol 123, Num 10, pp 2354-2361, issn 0020-7136, 8 p.Article

Pemetrexed in Combination With Cisplatin Versus Cisplatin Monotherapy in Patients With Recurrent or Metastatic Head and Neck CancerURBA, Susan; VAN HERPEN, Carla M. L; HOSSAIN, Anwar M et al.Cancer. 2012, Vol 118, Num 19, pp 4694-4705, issn 0008-543X, 12 p.Article

Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza VaccinationMULDER, Sasja F; JACOBS, Joannes F. M; DE VRIES, I. Jolanda M et al.Clinical cancer research (Print). 2011, Vol 17, Num 13, pp 4541-4549, issn 1078-0432, 9 p.Article

Factors affecting the unexpected failure of DCE-MRI to determine the optimal biological dose of the vascular targeting agent NGR-hTNF in solid cancer patientsDESAR, Ingrid M. E; VAN HERPEN, Carla M. L; VAN LAARHOVEN, Hanneke W. M et al.European journal of radiology. 2011, Vol 80, Num 3, pp 655-661, issn 0720-048X, 7 p.Article